CSIR-IICT collaborates with Carbanio to digitally source chemicals

Our Bureau Hyderabad | Updated on May 11, 2020 Published on May 11, 2020

The R&D work at CSIR-IICT on re-purposing of drugs such as Favipiravir, Remdesivir and Hydroxychloroquine, as anti-Covid-19 solutions in collaboration with pharmaceutical companies was facilitated with unhindered supply chain of raw materials by Carbanio during the lockdown period.

S Chandrasekhar, Director, CSIR-IICT, acknowledges the timely support extended by Carbanio, India’s leading B2B chemicals marketplace, founded by Rafi S in catering to the demand of all raw materials and the key building blocks as per our custom requirements.

The scientists working in Covid-19 projects at CSIR-IICT expressed that realising the potential of digital platforms in quick chemicals sourcing, which is the key to meet the timely milestone deliverables of projects, the lab is interested to collaborate with Carbanio for their chemical requirements, according to a statement.

Carbanio has a strong customer base across India and is recognised by the Department for Promotion of Industry and Internal Trade. It has over 51 lakh chemical products from sellers across India. It also offers unused chemicals for free to research institutions that quench the costs and help make R&D more affordable.

Published on May 11, 2020

A letter from the Editor

Dear Readers,

The coronavirus crisis has changed the world completely in the last few months. All of us have been locked into our homes, economic activity has come to a near standstill. Everyone has been impacted.

Including your favourite business and financial newspaper. Our printing and distribution chains have been severely disrupted across the country, leaving readers without access to newspapers. Newspaper delivery agents have also been unable to service their customers because of multiple restrictions.

In these difficult times, we, at BusinessLine have been working continuously every day so that you are informed about all the developments – whether on the pandemic, on policy responses, or the impact on the world of business and finance. Our team has been working round the clock to keep track of developments so that you – the reader – gets accurate information and actionable insights so that you can protect your jobs, businesses, finances and investments.

We are trying our best to ensure the newspaper reaches your hands every day. We have also ensured that even if your paper is not delivered, you can access BusinessLine in the e-paper format – just as it appears in print. Our website and apps too, are updated every minute, so that you can access the information you want anywhere, anytime.

But all this comes at a heavy cost. As you are aware, the lockdowns have wiped out almost all our entire revenue stream. Sustaining our quality journalism has become extremely challenging. That we have managed so far is thanks to your support. I thank all our subscribers – print and digital – for your support.

I appeal to all or readers to help us navigate these challenging times and help sustain one of the truly independent and credible voices in the world of Indian journalism. Doing so is easy. You can help us enormously simply by subscribing to our digital or e-paper editions. We offer several affordable subscription plans for our website, which includes Portfolio, our investment advisory section that offers rich investment advice from our highly qualified, in-house Research Bureau, the only such team in the Indian newspaper industry.

A little help from you can make a huge difference to the cause of quality journalism!

Support Quality Journalism
  1. Comments will be moderated by The Hindu Business Line editorial team.
  2. Comments that are abusive, personal, incendiary or irrelevant cannot be published.
  3. Please write complete sentences. Do not type comments in all capital letters, or in all lower case letters, or using abbreviated text. (example: u cannot substitute for you, d is not 'the', n is not 'and').
  4. We may remove hyperlinks within comments.
  5. Please use a genuine email ID and provide your name, to avoid rejection.
You have read 1 out of 3 free articles for this week. For full access, please subscribe and get unlimited access to all sections.